CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

By K. F. Schulz, Douglas G. Altman, David Moher. Trials, 2010

971 citations recorded by the source corpus.

The CONSORT statement is used worldwide to improve the reporting of randomised controlled trials. Kenneth Schulz and colleagues describe the latest version, CONSORT 2010, which updates the reporting guideline based on new methodological evidence and accumulating experience.To encourage dissemination of the CONSORT 2010 Statement, this article is freely accessible on bmj.com and will also be published in the Lancet, Obstetrics and Gynecology, PLoS Medicine, Annals of Internal Medicine, Open Medicine, Journal of Clinical Epidemiology, BMC Medicine, and Trials.

Subfields: Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health, Statistics and Probability

View Paper: https://www.semanticscholar.org/paper/98910daf518f68f480fbbce09e96b8dcd6602bd3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Douglas G. Altman
2. David Moher
3. K. F. Schulz
4. Karel G. M. Moons
5. Gary S. Collins
6. Johannes B Reitsma

In Public Health, Environmental and Occupational Health

1. David Moher
2. Douglas G. Altman
3. K. F. Schulz
4. H. Sox
5. J. Gagnier
6. G. Kienle
7. David Riley
8. I. Boutron

In Statistics and Probability

1. David Moher
2. Douglas G. Altman
3. K. F. Schulz
4. I. Boutron
5. J. Gagnier
6. H. Sox
7. G. Kienle
8. David Riley

Citations in the corpus

• CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts. (2017, positive): “In 2010, the main CONSORT Statement was updated (5, 18).”
• The CARE guidelines: consensus-based clinical case reporting guideline development (2013, positive): “Reporting guidelines exist for a variety of study designs including randomized controlled trials (Consolidated Standards of Reporting Trials, or CONSORT) [10], observational studies (Strengthening the Reporting of Observational studies in Epidemiology, or STROBE) [11], and systematic reviews and met”
• Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration (2012, neutral): “The flow diagram is an important element of the Consolidated Standards of Reporting Trials (CONSORT) Statement, which was developed to improve reporting of randomized controlled trials (RCTs) [8,22,23].”
• Patient risk factors for pressure ulcer development: systematic review. (2013, neutral): “Smoking 2 of 4 (50%) 1 MQS – Suriadi et al. (2008) 1 LQS – Suriadi et al.”
• STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration (2016, neutral): “7 Inspired by the Consolidated Standards for the Reporting of Trials or CONSORT statement for reporting randomised controlled trials, 8 9 STARD contains a checklist of items that should be reported in any diagnostic accuracy study.”